Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00108615 · ClinicalTrials.gov registry record · Phase 4
Effects of Insulin Sensitizers in Subjects With Impaired Glucose Tolerance
A Phase 4 study, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- Phase 4
- Development phase
- 48
- Enrollment target
NCT00108615 is a Phase 4 study that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 48 participants.
The verdict
NCT00108615, a Phase 4 study, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 48 participants
- Enrollment target
Study Summary
Subjects with impaired glucose tolerance will be randomized to receive pioglitazone or metformin for 10 weeks. Measurements of insulin sensitivity, body composition, glucose tolerance, and muscle lipid accumulation will be performed. Adipose tissue and muscle biopsies are performed. The goal of the study is to determine whether the lipotoxiciy of impaired glucose tolerance is ameliorated by pioglitazone.
Interventions
- DRUG Metformin
- DRUG Pioglitazone
- RADIATION CT scans
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2004-01 |
| Est. Completion | 2007-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00108615
The ClinicalTrials.gov registry entry for NCT00108615 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is US Department of Veterans Affairs, which has 632 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Metformin is the first listed.
NCT00108615 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00108615 about?
NCT00108615 is a clinical study titled "Effects of Insulin Sensitizers in Subjects With Impaired Glucose Tolerance". Subjects with impaired glucose tolerance will be randomized to receive pioglitazone or metformin for 10 weeks. Measurements of insulin sensitivity, body composition, glucose tolerance, and muscle lipid accumulation will be performed. Adipose tissue and muscle biopsies are performed. The goal of the ...
What is the current status of trial NCT00108615?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 48 participants. The study started on 2004-01. Estimated completion is 2007-12.
What interventions are being tested in trial NCT00108615?
The interventions under investigation include: Metformin (DRUG), Pioglitazone (DRUG), CT scans (RADIATION).
Who is sponsoring clinical trial NCT00108615?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.